Article
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb
17 Jan 2019
Abstract excerpt
Comprehensively elucidating the molecular mechanisms of human immunodeficiency virus type 1 (HIV-1) latency is a priority to achieve a functional cure. As current 'shock' agents failed to efficiently reactivate the latent reservoir, it is important to discover new targets for developing more efficient latency-reversing agents (LRAs). Here, we found that TRIM28 potently suppresses HIV-1 expression by utilizing...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
